Last reviewed · How we verify
NCT03732755
PoNS Clinical Experience Program (TBI)
NA trial testing PoNS Treatment in Mild to Moderate Traumatic Brain Injury in 20 participants. Status unknown.
30 November 2019
Quick facts
| Lead sponsor | Helius Medical Inc |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 1 April 2019 |
| Primary completion | 30 November 2019 |
| Estimated completion | 30 November 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- PoNS Treatment
Conditions studied
- Mild to Moderate Traumatic Brain Injury — all drugs for Mild to Moderate Traumatic Brain Injury →
Sponsor
Helius Medical Inc
Who can join
18 and older, any sex, with Mild to Moderate Traumatic Brain Injury. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
\- Brief Summary: Prospective, cohort, open-label study. The cohort consists of people who have a chronic balance dysfunction due to a mild to moderate traumatic brain injury (TBI). All participants will participate in a 14-week PoNS Treatment protocol - a combination of symptom specific physical exercises and repeated use of the PoNS device. Subjects who meet the initial screening entrance criteria will be scheduled for a baseline assessment to evaluate balance and gait. Subjects will then begin the PoNS Treatment program and re-perform some assessments at 2, 5 and 14 weeks evaluating their functional improvements.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03732755
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of PoNS Treatment
Trials testing the same drug.
- NCT03852732 — PoNS Clinical Experience Program (TBI) · NA · unknown
- NCT03881176 — PoNS Clinical Experience Program in Traumatic Brain Injury Patients (TBI) · NA · completed
- NCT03882554 — PoNS Clinical Experience Program (TBI) · NA · unknown
- NCT03881202 — PoNS Clinical Experience Program (TBI) · NA · unknown
Other recruiting trials for Mild to Moderate Traumatic Brain Injury
Currently open trials in the same condition.
- NCT07190365 — Goal-oriented Telehealth Rehabilitation of Executive Functioning for Veterans With Chronic TBI · NA · recruiting
Other Helius Medical Inc trials
Trials by the same sponsor.
- NCT06470009 — Portable Neuromodulation Stimulator (PoNS®) Therapy for Gait and Balance Deficits in Chronic Stroke Survivors: A Randomi · NA · active not recruiting
- NCT06336720 — PoNS® Therapy for Gait and Balance Deficits in Chronic Stroke Survivors: A Single-Arm Study · NA · active not recruiting
- NCT06930339 — Portable Neuromodulation Stimulator Registry for People With Multiple Sclerosis · active not recruiting
- NCT05437276 — A Therapeutic Experience Program (TEP) Study for Improvement of Gait in People With Multiple Sclerosis (MS) · completed
- NCT03852732 — PoNS Clinical Experience Program (TBI) · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03732755 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Helius Medical Inc
- Last refreshed: 20 March 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03732755.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing